A Phase II Multicenter Study of Visilizumab, Humanized Anti-CD3 Antibody, to Treat Steroid-Refractory Acute Graft-versus-Host Disease

Autor: Carpenter, Paul A., Lowder, James, Johnston, Laura, Frangoul, Haydar, Khoury, Hanna, Parker, Pablo, Jerome, Keith R., McCune, Jeannine S., Storer, Barry, Martin, Paul, Appelbaum, Frederick, Abonour, Rafat, Westervelt, Peter, Anasetti, Claudio
Zdroj: In Biology of Blood and Marrow Transplantation 2005 11(6):465-471
Databáze: ScienceDirect
Externí odkaz: